Heidelberg Pharma AG
XMUN:HPHA
Heidelberg Pharma AG
XMUN:HPHA
Price:
2.78
EUR
-0.71%
Market Cap:
€129.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
H
|
Heidelberg Pharma AG
XMUN:HPHA
|
DE |
|
Altus Power Inc
F:8770
|
US |
|
R
|
Ross Stores Inc
F:RSO
|
US |
|
A
|
Avis Budget Group Inc
XMUN:CUCA
|
US |
|
B
|
Bure Equity AB
F:BLZ
|
SE |
|
G
|
Gap Inc
DUS:GAP
|
US |
|
Advanced Micro Devices Inc
NASDAQ:AMD
|
US |
|
Oxford Square Capital Corp
F:22T
|
US |
|
M
|
Mondelez International Inc
XMUN:KTF
|
US |
Wall St Price Targets
HPHA Price Targets Summary
Heidelberg Pharma AG
Heidelberg Pharma AG
Wall Street analysts forecast HPHA stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for HPHA is 5.47 EUR with a low forecast of 5.42 EUR and a high forecast of 5.63 EUR.
Lowest Forecast
Price Target
5.42
EUR
95% Upside
Average Forecast
Price Target
5.47
EUR
97% Upside
Highest Forecast
Price Target
5.63
EUR
103% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HPHA's stock price target?
Price Target
5.47
EUR
5.47
EUR
According to Wall Street analysts, the average 1-year price target for HPHA is 5.47 EUR with a low forecast of 5.42 EUR and a high forecast of 5.63 EUR.
What is the Revenue forecast for Heidelberg Pharma AG?
Projected CAGR
202%
202%
Over the last 9 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 2 years is 202%.
